James Paul Rickey - Senior VP and CFO, Alpine Immune Sciences, Inc

As of January 6, 2021


James Paul Rickey Net Worth

  • Net worth is estimated to be at least $260.32K
  • Owns at least 10,000 units of Alpine Immune Sciences, Inc stock
  • Sold an estimated value of $50.38K in the last 4 years at Alpine Immune Sciences, Inc

James Paul Rickey Compensation at Alpine Immune Sciences, Inc in 2020

  • Earned a $382,000 salary
  • Received a total compensation of $765,815

James Paul Rickey Trading

  • Largest purchase of shares was 10,000 units , worth over $49.5K on June 3, 2019
  • In total has made about 8 transactions over 4 years
  • Usually trades in January, with the busiest year in 2021, 2020 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James Paul Rickey Mailing Address

  • Mailing address is Alpine Immune Sciences, Inc. 188 East Blaine Street, Suite 200 Seattle WA 98102 WA

Alpine Immune Sciences, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Total
Mitchell H. Gold, M.D. 2020 $500,000 $566,512 $317,500 $1,384,012
Mitchell H. Gold, M.D. 2019 $485,000 $852,681 $218,250 $1,555,931
Stanford Peng, M.D., Ph.D. 2020 $464,000 $226,605 $294,640 $985,245
Stanford Peng, M.D., Ph.D. 2019 $442,708 $319,757 $208,126 $970,591
Paul Rickey 2020 $382,000 $214,016 $169,799 $765,815
Paul Rickey 2019 $370,000 $319,757 $119,788 $809,545
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1626199/000162619921000048/defproxy_2020.htm

Alpine Immune Sciences, Inc Insider Trading

  • The most recent transaction was 15,000 units bought on September 24, 2021 by Robert Conway worth over $151.15K
  • In the last 2 years, insiders at Alpine Immune Sciences, Inc sold an estimated value of $31.3M and bought an estimated value of $76.53M
  • The most active traders are Mitchell Gold, Executive Chairman and CEO,  Jay Venkatesan, Director,  and Stanford Peng, See Remarks
  • Insider trading is most common in January, with the busiest year in 2021

ALPINE IMMUNE SCIENCES, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1